117 related articles for article (PubMed ID: 31577277)
1. [The use of MR perfusion in assessing the efficacy of treatment for malignant brain tumors].
Rebrikova VA; Sergeev NI; Padalko VV; Kotlyarov PM; Solodkiy VA
Zh Vopr Neirokhir Im N N Burdenko; 2019; 83(4):113-120. PubMed ID: 31577277
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis.
Masch WR; Wang PI; Chenevert TL; Junck L; Tsien C; Heth JA; Sundgren PC
Acad Radiol; 2016 May; 23(5):569-76. PubMed ID: 26916251
[TBL] [Abstract][Full Text] [Related]
3. Contrast-Enhanced Perfusion MR Imaging to Differentiate Between Recurrent/Residual Brain Neoplasms and Radiation Necrosis.
Metaweh NAK; Azab AO; El Basmy AAH; Mashhour KN; El Mahdy WM
Asian Pac J Cancer Prev; 2018 Apr; 19(4):941-948. PubMed ID: 29693348
[TBL] [Abstract][Full Text] [Related]
4. Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy.
Bobek-Billewicz B; Stasik-Pres G; Majchrzak H; Zarudzki L
Folia Neuropathol; 2010; 48(2):81-92. PubMed ID: 20602289
[TBL] [Abstract][Full Text] [Related]
5. Combined use of susceptibility weighted magnetic resonance imaging sequences and dynamic susceptibility contrast perfusion weighted imaging to improve the accuracy of the differential diagnosis of recurrence and radionecrosis in high-grade glioma patients.
Kim TH; Yun TJ; Park CK; Kim TM; Kim JH; Sohn CH; Won JK; Park SH; Kim IH; Choi SH
Oncotarget; 2017 Mar; 8(12):20340-20353. PubMed ID: 27823971
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
[TBL] [Abstract][Full Text] [Related]
7. Dynamic magnetic resonance perfusion imaging of brain tumors.
Covarrubias DJ; Rosen BR; Lev MH
Oncologist; 2004; 9(5):528-37. PubMed ID: 15477637
[TBL] [Abstract][Full Text] [Related]
8. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
[TBL] [Abstract][Full Text] [Related]
9. Potential for differentiation of glioma recurrence from radionecrosis using integrated
Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia imaging in brain tumors.
Yetkin FZ; Mendelsohn D
Neuroimaging Clin N Am; 2002 Nov; 12(4):537-52. PubMed ID: 12687910
[TBL] [Abstract][Full Text] [Related]
11. The value of
Garcia JR; Cozar M; Baquero M; Fernández Barrionuevo JM; Jaramillo A; Rubio J; Maida G; Soler M; Riera E
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):85-90. PubMed ID: 27503425
[TBL] [Abstract][Full Text] [Related]
12. The role of Tc-99m HMPAO functional brain imaging in detection of cerebral radionecrosis.
Dadparvar S; Hussain R; Koffler SP; Gillan MM; Bartolic EI; Miyamoto C
Cancer J; 2000; 6(6):381-7. PubMed ID: 11131488
[TBL] [Abstract][Full Text] [Related]
13. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.
Kumar AJ; Leeds NE; Fuller GN; Van Tassel P; Maor MH; Sawaya RE; Levin VA
Radiology; 2000 Nov; 217(2):377-84. PubMed ID: 11058631
[TBL] [Abstract][Full Text] [Related]
14. Radionecrosis versus disease progression in brain metastasis. Value of (18)F-DOPA PET/CT/MRI.
Hernández Pinzón J; Mena D; Aguilar M; Biafore F; Recondo G; Bastianello M
Rev Esp Med Nucl Imagen Mol; 2016; 35(5):332-5. PubMed ID: 27117985
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of Recurrent/Residual Glioma From Radiation Necrosis Using Semi Quantitative 99mTc MDM (Bis-Methionine-DTPA) Brain SPECT/CT and Dynamic Susceptibility Contrast-Enhanced MR Perfusion: A Comparative Study.
Rani N; Singh B; Kumar N; Singh P; Hazari PP; Singh H; Kumar G; Radotra B; Kumar M; Bhattacharya A; Sharma R; Kohli A; Chhabra R; Gupta SK; Mishra AK
Clin Nucl Med; 2018 Mar; 43(3):e74-e81. PubMed ID: 29356734
[TBL] [Abstract][Full Text] [Related]
16. Relative cerebral blood volume is a potential biomarker in late delayed radiation-induced brain injury.
Xie Y; Huang H; Guo J; Zhou D
J Magn Reson Imaging; 2018 Apr; 47(4):1112-1118. PubMed ID: 28796443
[TBL] [Abstract][Full Text] [Related]
17. [Magnetic resonance perfusion weighted imaging manifestation of late radiation-induced encephalopathy at temporal lobe].
Zhao JQ; Liang BL; Shen J; Zhang XH; Sun Y
Ai Zheng; 2005 Sep; 24(9):1102-5. PubMed ID: 16159433
[TBL] [Abstract][Full Text] [Related]
18. First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors from radiation effects and radiation necrosis.
Jain R; Scarpace L; Ellika S; Schultz LR; Rock JP; Rosenblum ML; Patel SC; Lee TY; Mikkelsen T
Neurosurgery; 2007 Oct; 61(4):778-86; discussion 786-7. PubMed ID: 17986939
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in imaging of brain tumors.
Sanghvi DA
Indian J Cancer; 2009; 46(2):82-7. PubMed ID: 19346641
[TBL] [Abstract][Full Text] [Related]
20. Absolute CBV for the differentiation of recurrence and radionecrosis of brain metastases after gamma knife radiotherapy: a comparison with relative CBV.
Wang B; Zhao B; Zhang Y; Ge M; Zhao P; Na Sun ; Li C; Pang Q; Xu S; Liu Y
Clin Radiol; 2018 Aug; 73(8):758.e1-758.e7. PubMed ID: 29764622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
